...PIK3CA and/or PTEN mutations were more likely to be RS (P = 0.0123). Akt phosphorylation (S473 and T308) was significant...
...PIK3CA mutations) were examined along bowel subsites (rectum, rectosigmoid junction, sigmoid, descending colon, splenic ...
...PIK3CA colorectal cancer, but not among patients with wild-type PIK3CA cancer. The findings from this molecular patholog...
...PIK3CA and GATA3) occurred at >10% incidence across all breast cancers; however, there were numerous subtype-associated ...
...PIK3CA, HIF1A, IL8, MMP2, and MMP9 message by real-time quantitative polymerase chain reaction. The expression of each g...
...PIK3CA mutation status. These results confirm the interest of targeting VEGFA and PARP1 in ongoing clinical trials in TN...
...PIK3CA mutation and/or PIK3CA amplification.,Molecular genetic aberrations involving the p53, cyclin E-FBXW7, and PI3K p...
...PIK3CA and AKT1 genes are promising therapeutic targets in breast cancer. In 60% to 70% of malignant melanomas, a mutati...
...PIK3CA status in their bone metastases. For each of these, the PIK3CA mutation status was the same in the primary and me...
...PIK3CA, INSR, LTK, and MERTK genes. In particular, seven novel mutations in addition to known KRAS mutations were observ...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
